206 posters, 13 topics, 5 sessions, 713 authors, 293 institutions
ePostersLive by SciGen Technologies S.A. All rights reserved.
AAPS 104th Annual Meeting
May 2-5, 2026 | Lihue, HI
PC4
Surgical Outcomes Of Patients Receiving GLP-1 Receptor Agonists Undergoing Breast Reduction Surgery: A Propensity Score-matching Analysis
Poster Presenter
Authors
Diane Saab, Charlotte Thomas, Alynah Adams, Fatima Arif, Sanjana Challa, Samuel J. Lin
Affiliations
University of Texas Southwestern Medical School, University of Texas Southwestern Medical School, Dallas, TX, Division of Plastic and Reconstructive Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
Part of Topic
Aesthetic Breast/Body Contouring
As GLP-1 receptor agonists (semaglutide, tirzepatide) become increasingly common in patients seeking elective plastic surgery, their impact on wound healing remains poorly characterized. Using TriNetX and 1:1 propensity score matching on 24 covariates, we compared 30-, 90-, 180-, and 365-day postoperative outcomes in breast reduction patients with and without prior GLP-1 use. GLP-1 therapy was not associated with increased major complications but was linked to higher post-procedural wound care utilization and lower fat necrosis at one year.